English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#angiodynamics search results

Earnings_Time's profile picture. Real-time earnings reports and insights
EarningsTime
@Earnings_Time
Oct 3, 2024

#AngioDynamics, $ANGO, Q1 FY25 Results: 🟢+1.4% Pre Market ($7.76) 📊 Adj EPS: $(0.11) 🟢 💰 Revenue: $67.50M 🔴 📉 Net Loss: $(12.80)M 🔍 Med Tech net sales grew 8.7%, driven by strong performance in Auryon and AlphaVac platforms.

Earnings_Time's tweet image. #AngioDynamics, $ANGO, Q1 FY25 Results: 🟢+1.4% Pre Market ($7.76) 📊 Adj EPS: $(0.11) 🟢 💰 Revenue: $67.50M 🔴 📉 Net Loss: $(12.80)M 🔍 Med Tech net sales grew 8.7%, driven by strong performance in Auryon and AlphaVac platforms.
1
0
3
0
182
Beachdudeca's profile picture. Managed Corporate Credit currently a Trader / Investor. Mostly using my Feed to Journal my DayTrading Reference Notes . Historic Mass Layoffs see Highlights.
Joseph Angelo
@Beachdudeca
Jan 11, 2024

#AngioDynamics $ANGO closing facility in #Latham, this healthcare device manufacturer that turned Warren County into “Catheter Valley” announced the shutdown of their manufacturing facilities in #Queensbury and #GlensFalls by the second half of 2025. #NewYork Upwards of 350

0
0
0
0
93
PrismMarketView's profile picture. The PRISM stock indexes track small/micro-cap companies across a diverse spectrum of industries including clean energy, biotech and next-gen tech.
PRISM MarketView
@PrismMarketView
Apr 2, 2025

AngioDynamics Shares Rise on Strong Third Quarter Growth and Increased Fiscal 2025 Guidance @angiodynamics, Inc. (NASDAQ: $ANGO) #AngioDynamics #StocksOnTheMove #StocksInNews #investors #daytrader #PRISMMediaWire #PRISMDigitalMedia #StocksOnTheMove #StocksInNews #investors

0
0
0
0
43
AngioDynamicsCV's profile picture. We believe advancing care starts with trusting and investing in those who provide it. Risk Information: https://t.co/VAGvxJTRBW
AngioDynamics Cardiovascular
 @AngioDynamicsCV
Aug 12

We look forward to an event of engaging sessions, expert clinical and scientific perspectives, and meaningful insights. Visit the #Auryon team at Booth 302. ▶️ bit.ly/47aRiYV @AMPSymposium #AngioDynamics #TheAuryonSystem #AMP2025 Risk Info: bit.ly/3IOQLC2

AngioDynamicsCV's tweet image. We look forward to an event of engaging sessions, expert clinical and scientific perspectives, and meaningful insights. Visit the #Auryon team at Booth 302. ▶️ bit.ly/47aRiYV @AMPSymposium #AngioDynamics #TheAuryonSystem #AMP2025 Risk Info: bit.ly/3IOQLC2
0
0
1
0
24
CrweWorld's profile picture.
Crwe World
 @CrweWorld
Oct 3, 2024

AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results $ANGO, #AngioDynamics crweworld.com/article/news-p…

0
0
0
0
24
Finmake_over's profile picture. Value investor
Code & Coin
 @Finmake_over
Jul 13, 2023

#AngioDynamics $ANGO #Q4 #earnings : Revenue up 4.7% YoY to $91.1M, driven by strong growth in Med Tech segment. Auryon PAD business soars with 41% revenue increase! #MedTech #FinancialResults #EarningsCall prospermetrics.com/investorbriefs…

Finmake_over's tweet image. #AngioDynamics $ANGO #Q4 #earnings : Revenue up 4.7% YoY to $91.1M, driven by strong growth in Med Tech segment. Auryon PAD business soars with 41% revenue increase! #MedTech #FinancialResults #EarningsCall prospermetrics.com/investorbriefs…
0
0
0
0
23
CrweWorld's profile picture.
Crwe World
 @CrweWorld
Jul 16, 2024

AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results $ANGO, #AngioDynamics crweworld.com/article/news-p…

0
0
0
0
44
AndrewRoboticIO's profile picture. Robotics & IO Specialist (17 yrs), happily married (18 yrs) father of 2 awesome kids & dad to 100,000 🐝 All through God’s grace.
Andrew Zeringue
 @AndrewRoboticIO
May 2, 2023

I was on the launch team for #NanoKnife in 2008 and now representing #Epione Robot it brings me great joy to see these 2 technologies used in conjunction for the FIRST TIME EVER in the world!!! Great work Prof. Laurent Milot! #AngioDynamics #QuantumSurgical #ablation #IRE

AndrewRoboticIO's tweet image. I was on the launch team for #NanoKnife in 2008 and now representing #Epione Robot it brings me great joy to see these 2 technologies used in conjunction for the FIRST TIME EVER in the world!!! Great work Prof. Laurent Milot! #AngioDynamics #QuantumSurgical #ablation #IRE
0
0
2
0
127
CrweWorld's profile picture.
Crwe World
 @CrweWorld
Jul 29, 2024

AngioDynamics to Participate in Upcoming Investor Conferences $ANGO, #AngioDynamics crweworld.com/article/news-p…

0
0
0
0
33
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Feb 18, 2023

Is this good for your portfolio? $ANGO price moved above its 50-day Moving Average. #AngioDynamics srnk.us/go/4416397

Tickeron's tweet image. Is this good for your portfolio? $ANGO price moved above its 50-day Moving Average. #AngioDynamics srnk.us/go/4416397
0
0
0
0
59
GoWithPINE's profile picture. New England’s most advanced prostate health organization utilizing the latest procedures in diagnostic testing and minimally invasive treatments.
Prostate Institute of New England
 @GoWithPINE
Oct 13

Big news in focal therapy: Nanoknife has been named one of @TIME's Best Inventions of 2025. This recognition reflects the innovative work being done in the ever-evolving field of focal therapy #NanoKnife #AngioDynamics #ProstateCancer #Urology loom.ly/qVo2yOA

GoWithPINE's tweet card. Find out why AngioDynamics NanoKnife is on TIME's list of 2025's best inventions.
AngioDynamics NanoKnife: The Best Inventions of 2025
Source: time.com
0
0
0
0
16
angiodynamics's profile picture. A leading provider of innovative, minimally invasive medical devices used by healthcare providers for vascular access, peripheral vascular disease, and oncology
AngioDynamics, Inc.
@angiodynamics
Feb 14

Your health reminds us why we do what we do – and AngioDynamics takes it to heart. Risk Info: Medical Technologies and Devices Risk Information | AngioDynamics #HeartAwarenessMonth #AngioDynamics #TakeIttoHeart

0
0
1
0
71
angiodynamics's profile picture. A leading provider of innovative, minimally invasive medical devices used by healthcare providers for vascular access, peripheral vascular disease, and oncology
AngioDynamics, Inc.
@angiodynamics
Apr 28

Precision you can trust. Learn more about how accurate and dependable Accu-Vu® Sizing Angiographic Catheters are. Visit us: angiodynamics.com/product/angiog… Risk info: angiodynamics.com/about-us/risk-… #AccuVu #AngioDynamics #PatientCare

0
0
0
0
31
AngioDynamicsCV's profile picture. We believe advancing care starts with trusting and investing in those who provide it. Risk Information: https://t.co/VAGvxJTRBW
AngioDynamics Cardiovascular
 @AngioDynamicsCV
Apr 17

Join team #Angio at our upcoming Satellite Session at #SCAI2026 Thursday, 4/23, 6:00-7:30 PM. Located at 510a, level 5. Risk Info: bit.ly/4mg2mI9 #AngioDynamics #PE #AlphaVac #Thrombectomy #CardiovascularCare

AngioDynamicsCV's tweet image. Join team #Angio at our upcoming Satellite Session at #SCAI2026 Thursday, 4/23, 6:00-7:30 PM. Located at 510a, level 5. Risk Info: bit.ly/4mg2mI9 #AngioDynamics #PE #AlphaVac #Thrombectomy #CardiovascularCare
0
1
2
0
26
angiodynamics's profile picture. A leading provider of innovative, minimally invasive medical devices used by healthcare providers for vascular access, peripheral vascular disease, and oncology
AngioDynamics, Inc.
@angiodynamics
Apr 14

Precision you can see with your own eyes. Learn more about how accurate and dependable Accu-Vu® Sizing Angiographic Catheters are. Visit us: angiodynamics.com/product/angiog… Risk info: angiodynamics.com/about-us/risk-… #AccuVu #AngioDynamics #PatientCare

0
0
0
0
60
AngioDynamicsCV's profile picture. We believe advancing care starts with trusting and investing in those who provide it. Risk Information: https://t.co/VAGvxJTRBW
AngioDynamics Cardiovascular
 @AngioDynamicsCV
Apr 13

The Exhibit Hall is open at #SIR26TOR - stop by the AngioDynamics booth #523 today between 9:15 AM-3:15 PM to learn more about our Cardiovascular solutions. #AngioDynamics #Auryon #AngioVac #AlphaVac #SIR26TOR

AngioDynamicsCV's tweet image. The Exhibit Hall is open at #SIR26TOR - stop by the AngioDynamics booth #523 today between 9:15 AM-3:15 PM to learn more about our Cardiovascular solutions. #AngioDynamics #Auryon #AngioVac #AlphaVac #SIR26TOR
AngioDynamicsCV's tweet image. The Exhibit Hall is open at #SIR26TOR - stop by the AngioDynamics booth #523 today between 9:15 AM-3:15 PM to learn more about our Cardiovascular solutions. #AngioDynamics #Auryon #AngioVac #AlphaVac #SIR26TOR
AngioDynamicsCV's tweet image. The Exhibit Hall is open at #SIR26TOR - stop by the AngioDynamics booth #523 today between 9:15 AM-3:15 PM to learn more about our Cardiovascular solutions. #AngioDynamics #Auryon #AngioVac #AlphaVac #SIR26TOR
0
0
1
0
12
PenkeInvesting's profile picture. I help you understand the business behind a stock. Based on numbers, not emotions. Compound your knowledge & your money compounds faster over time. Penke 🥸
Penke Investing
@PenkeInvesting
Apr 6

Fundamental analysis of $ANGO (ANGIODYNAMICS INC) based on financial data and reported results. #ANGO #ANGIODYNAMICS

PenkeInvesting's tweet image. Fundamental analysis of $ANGO (ANGIODYNAMICS INC) based on financial data and reported results. #ANGO #ANGIODYNAMICS
0
0
0
0
61
fazencapital's profile picture. Market Insights & Financial Analysis
Fazen Capital
@fazencapital
Apr 6

AngioDynamics Shares Slip After Canaccord Cuts Target: Canaccord cut AngioDynamics' 12-month target on Apr 6, 2026, citing margin pressure; intraday moves were ~3–7%… dlvr.it/TRv1PL 👈 Read full analysis #AngioDynamics #Canaccord #StockMarket #Investing #FinancialNews

fazencapital's tweet image. AngioDynamics Shares Slip After Canaccord Cuts Target: Canaccord cut AngioDynamics' 12-month target on Apr 6, 2026, citing margin pressure; intraday moves were ~3–7%… dlvr.it/TRv1PL 👈 Read full analysis #AngioDynamics #Canaccord #StockMarket #Investing #FinancialNews
0
0
0
0
1
fazencapital's profile picture. Market Insights & Financial Analysis
Fazen Capital
@fazencapital
Apr 5

AngioDynamics Q3 2026 Results Show Revenue Miss: AngioDynamics reported $117.3M in Q3 2026 revenue (Apr 2, 2026), down 3.4% YoY; adjusted EPS $0.18 and… dlvr.it/TRtdZ3 👈 Read full analysis #AngioDynamics #QuarterlyResults #EarningsReport #Healthcare #MedicalDevices

fazencapital's tweet image. AngioDynamics Q3 2026 Results Show Revenue Miss: AngioDynamics reported $117.3M in Q3 2026 revenue (Apr 2, 2026), down 3.4% YoY; adjusted EPS $0.18 and… dlvr.it/TRtdZ3 👈 Read full analysis #AngioDynamics #QuarterlyResults #EarningsReport #Healthcare #MedicalDevices
0
0
0
0
0
investlust_com's profile picture. Global Stock Atlas – 47 Countries (free PDF) https://t.co/FSfPJ2AxcG
investlust.com
@investlust_com
Apr 3

Todays 24h drop leaders: #Polestar Automotive UK Class C-1 ADW $PSNYW -21% #AngioDynamics $ANGO -13% #Lindsay $LNN -12% #Knife Riv Co. $KNF -9% #Omeros $OMER -9% #NASDAQ #AfterHours #InvestorEducation #DailyGainers #EnergyStocks #ProfitWarning #52WeekLow

investlust_com's tweet image. Todays 24h drop leaders: #Polestar Automotive UK Class C-1 ADW $PSNYW -21% #AngioDynamics $ANGO -13% #Lindsay $LNN -12% #Knife Riv Co. $KNF -9% #Omeros $OMER -9% #NASDAQ #AfterHours #InvestorEducation #DailyGainers #EnergyStocks #ProfitWarning #52WeekLow
0
0
0
0
27
investlust_com's profile picture. Global Stock Atlas – 47 Countries (free PDF) https://t.co/FSfPJ2AxcG
investlust.com
@investlust_com
Apr 2

Todays 24h drop leaders: #Polestar Automotive UK Class C-1 ADW $PSNYW -21% #AngioDynamics $ANGO -12% #Lindsay $LNN -10% #Prestige Consumer Healthcare $PBH -10% #Regencell Bioscience $RGC -9% #USStocks #AfterHours #ChartOfTheDay #Investlust #MediaStocks #GuidanceCut

investlust_com's tweet image. Todays 24h drop leaders: #Polestar Automotive UK Class C-1 ADW $PSNYW -21% #AngioDynamics $ANGO -12% #Lindsay $LNN -10% #Prestige Consumer Healthcare $PBH -10% #Regencell Bioscience $RGC -9% #USStocks #AfterHours #ChartOfTheDay #Investlust #MediaStocks #GuidanceCut
0
0
0
0
65
CardiacVascNews's profile picture. News forum for top stories in Cardiac and Vascular to include cardiovascular, structural heart, PV, EVAR, TAVR, Interventional, neurovascular - @KenDropSearch
CardiacVascularNews
 @CardiacVascNews
Apr 2

New Post: AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability cardiacvascularnews.com/angiodynamics-… #angiodynamics

CardiacVascNews's tweet image. New Post: AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability cardiacvascularnews.com/angiodynamics-… #angiodynamics
0
0
0
0
5
AmerKadriMD's profile picture. Husband, Father of 4, IC Structuralist | Views are mine
Amer Kadri
 @AmerKadriMD
Mar 29

3/3 Discharged on IV antibiotics. GI workup planned given S. gallolyticus association with malignancy. #AngioVac #AngioDynamics #StructuralHeart #EPeeps #CardioTwitter #MedTwitter #Endocarditis #LeadExtraction @CovenantSaginaw

0
0
0
0
40
angiodynamics's profile picture. A leading provider of innovative, minimally invasive medical devices used by healthcare providers for vascular access, peripheral vascular disease, and oncology
AngioDynamics, Inc.
@angiodynamics
Mar 25

Less tPA. More peace of mind. Make the switch to ports that perform – because smoother flow matters. Click the link to find a sales rep near you ▶️ lnkd.in/e3BX47J5 Risk Info: bit.ly/3UFe4Rf #BioFlo #AngioDynamics #PatientCare 1. Carlo JT, Lamont JP,

0
0
0
1
119
angiodynamics's profile picture. A leading provider of innovative, minimally invasive medical devices used by healthcare providers for vascular access, peripheral vascular disease, and oncology
AngioDynamics, Inc.
@angiodynamics
Oct 9

We’re proud to announce that the AngioDynamics NanoKnife® System has been named one of @TIME’s Best Inventions of 2025. See the full list ▶️ time.com/collections/be… #AngioDynamics #NanoKnife #TIMEBestInventions #TIME #BestInventions2025 Risk information: bit.ly/3UFe4Rf

angiodynamics's tweet image. We’re proud to announce that the AngioDynamics NanoKnife® System has been named one of @TIME’s Best Inventions of 2025. See the full list ▶️ time.com/collections/be… #AngioDynamics #NanoKnife #TIMEBestInventions #TIME #BestInventions2025 Risk information: bit.ly/3UFe4Rf
0
0
0
0
528
angiodynamics's profile picture. A leading provider of innovative, minimally invasive medical devices used by healthcare providers for vascular access, peripheral vascular disease, and oncology
AngioDynamics, Inc.
@angiodynamics
Oct 6

President and CEO Jim Clemmer was featured on a recent episode of Let’s Talk Medtech ▶️ mddionline.com/cardiovascular… @MDDIonline #AngioDynamics #MedTech #LetsTalkMedtech Risk info > bit.ly/3UFe4Rf

angiodynamics's tweet image. President and CEO Jim Clemmer was featured on a recent episode of Let’s Talk Medtech ▶️ mddionline.com/cardiovascular… @MDDIonline #AngioDynamics #MedTech #LetsTalkMedtech Risk info > bit.ly/3UFe4Rf
0
0
1
0
105
AngioDynamicsCV's profile picture. We believe advancing care starts with trusting and investing in those who provide it. Risk Information: https://t.co/VAGvxJTRBW
AngioDynamics Cardiovascular
 @AngioDynamicsCV
Aug 12

We look forward to an event of engaging sessions, expert clinical and scientific perspectives, and meaningful insights. Visit the #Auryon team at Booth 302. ▶️ bit.ly/47aRiYV @AMPSymposium #AngioDynamics #TheAuryonSystem #AMP2025 Risk Info: bit.ly/3IOQLC2

AngioDynamicsCV's tweet image. We look forward to an event of engaging sessions, expert clinical and scientific perspectives, and meaningful insights. Visit the #Auryon team at Booth 302. ▶️ bit.ly/47aRiYV @AMPSymposium #AngioDynamics #TheAuryonSystem #AMP2025 Risk Info: bit.ly/3IOQLC2
0
0
1
0
24
Earnings_Time's profile picture. Real-time earnings reports and insights
EarningsTime
@Earnings_Time
Oct 3, 2024

#AngioDynamics, $ANGO, Q1 FY25 Results: 🟢+1.4% Pre Market ($7.76) 📊 Adj EPS: $(0.11) 🟢 💰 Revenue: $67.50M 🔴 📉 Net Loss: $(12.80)M 🔍 Med Tech net sales grew 8.7%, driven by strong performance in Auryon and AlphaVac platforms.

Earnings_Time's tweet image. #AngioDynamics, $ANGO, Q1 FY25 Results: 🟢+1.4% Pre Market ($7.76) 📊 Adj EPS: $(0.11) 🟢 💰 Revenue: $67.50M 🔴 📉 Net Loss: $(12.80)M 🔍 Med Tech net sales grew 8.7%, driven by strong performance in Auryon and AlphaVac platforms.
1
0
3
0
182
TheSchmidtFirm's profile picture. The Schmidt Firm, LLP has been recognized as one of the nation’s leading plaintiff’s law firms and handles cases in all 50 states.
Schmidt Firm, PLLC
 @TheSchmidtFirm
Apr 1, 2025

Lawsuits are being filed against AngioDynamics by patients who were injured by an Xcela Port Catheter. #AngioDynamics #Xcela #Chemotherapy #MDL #Recall - schmidtlaw.com/angiodynamics-…

TheSchmidtFirm's tweet image. Lawsuits are being filed against AngioDynamics by patients who were injured by an Xcela Port Catheter. #AngioDynamics #Xcela #Chemotherapy #MDL #Recall - schmidtlaw.com/angiodynamics-…
0
0
0
0
3
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Jan 28, 2023

$ANGO's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: srnk.us/go/4356528 #AngioDynamics

Tickeron's tweet image. $ANGO's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: srnk.us/go/4356528 #AngioDynamics
0
0
0
0
44
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Jan 30, 2023

$ANGO in Downtrend: Stochastic indicator sits in oversold zone for 11 days. View odds for this and other indicators: srnk.us/go/4361189 #AngioDynamics

Tickeron's tweet image. $ANGO in Downtrend: Stochastic indicator sits in oversold zone for 11 days. View odds for this and other indicators: srnk.us/go/4361189 #AngioDynamics
0
0
0
0
66
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Mar 31, 2023

If you’re trading this week, Read This! $ANGO MACD Histogram turned negative on March 30, 2023. #AngioDynamics srnk.us/go/4530348

Tickeron's tweet image. If you’re trading this week, Read This! $ANGO MACD Histogram turned negative on March 30, 2023. #AngioDynamics srnk.us/go/4530348
0
0
0
0
31
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Apr 26, 2023

How do you think the market will react to this? $ANGO MACD Histogram turned positive on April 25, 2023. #AngioDynamics srnk.us/go/4604193

Tickeron's tweet image. How do you think the market will react to this? $ANGO MACD Histogram turned positive on April 25, 2023. #AngioDynamics srnk.us/go/4604193
0
0
0
0
37
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Jul 11, 2023

AngioDynamics to report earnings on July 12, 2023. Earnings per share (EPS) estimate: $0.02 $ANGO #AngioDynamics srnk.us/go/4786784

Tickeron's tweet image. AngioDynamics to report earnings on July 12, 2023. Earnings per share (EPS) estimate: $0.02 $ANGO #AngioDynamics srnk.us/go/4786784
0
0
0
0
86
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Jan 27, 2023

$ANGO in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on January 5, 2023. View odds for this and other indicators: srnk.us/go/4351399 #AngioDynamics

Tickeron's tweet image. $ANGO in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on January 5, 2023. View odds for this and other indicators: srnk.us/go/4351399 #AngioDynamics
0
0
0
0
45
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Feb 18, 2023

Is this good for your portfolio? $ANGO price moved above its 50-day Moving Average. #AngioDynamics srnk.us/go/4416397

Tickeron's tweet image. Is this good for your portfolio? $ANGO price moved above its 50-day Moving Average. #AngioDynamics srnk.us/go/4416397
0
0
0
0
59
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Feb 2, 2023

This is amazing! What do you think? $ANGO price moved above its 50-day Moving Average. #AngioDynamics srnk.us/go/4370016

Tickeron's tweet image. This is amazing! What do you think? $ANGO price moved above its 50-day Moving Average. #AngioDynamics srnk.us/go/4370016
0
0
0
0
38
Finmake_over's profile picture. Value investor
Code & Coin
 @Finmake_over
Jul 13, 2023

#AngioDynamics $ANGO #Q4 #earnings : Revenue up 4.7% YoY to $91.1M, driven by strong growth in Med Tech segment. Auryon PAD business soars with 41% revenue increase! #MedTech #FinancialResults #EarningsCall prospermetrics.com/investorbriefs…

Finmake_over's tweet image. #AngioDynamics $ANGO #Q4 #earnings : Revenue up 4.7% YoY to $91.1M, driven by strong growth in Med Tech segment. Auryon PAD business soars with 41% revenue increase! #MedTech #FinancialResults #EarningsCall prospermetrics.com/investorbriefs…
0
0
0
0
23
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Apr 20, 2023

How do you think the market will react to this? $ANGO RSI Indicator left the oversold zone. #AngioDynamics srnk.us/go/4588803

Tickeron's tweet image. How do you think the market will react to this? $ANGO RSI Indicator left the oversold zone. #AngioDynamics srnk.us/go/4588803
0
0
0
0
61
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Feb 9, 2023

How will this affect the market? $ANGO entered Uptrend as Momentum indicator ascends above 0 level. #AngioDynamics srnk.us/go/4390310

Tickeron's tweet image. How will this affect the market? $ANGO entered Uptrend as Momentum indicator ascends above 0 level. #AngioDynamics srnk.us/go/4390310
0
0
0
0
57
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Jun 11, 2023

How will this affect the market? $ANGO RSI Indicator left the overbought zone. #AngioDynamics srnk.us/go/4718627

Tickeron's tweet image. How will this affect the market? $ANGO RSI Indicator left the overbought zone. #AngioDynamics srnk.us/go/4718627
0
0
0
0
51
dailyhornetnews's profile picture. News That Stings
Daily Hornet
 @dailyhornetnews
Apr 1, 2025

A man undergoing chemotherapy needed surgery to remove his Xcela Port Catheter after developing blood clots and other complications. #Xcela #AngioDynamics #MDL #Chemotherapy - dailyhornet.com/2025/cancer-pa…

dailyhornetnews's tweet image. A man undergoing chemotherapy needed surgery to remove his Xcela Port Catheter after developing blood clots and other complications. #Xcela #AngioDynamics #MDL #Chemotherapy - dailyhornet.com/2025/cancer-pa…
0
0
0
0
9
angiodynamics's profile picture. A leading provider of innovative, minimally invasive medical devices used by healthcare providers for vascular access, peripheral vascular disease, and oncology
AngioDynamics, Inc.
@angiodynamics
Feb 4

At AngioDynamics, we honor the hands that care — and the hearts they protect. Recognizing Heart Awareness Month with gratitude and purpose. Risk Info: Medical Technologies and Devices Risk Information | AngioDynamics #HeartAwarenessMonth #AngioDynamics

angiodynamics's tweet image. At AngioDynamics, we honor the hands that care — and the hearts they protect. Recognizing Heart Awareness Month with gratitude and purpose. Risk Info: Medical Technologies and Devices Risk Information | AngioDynamics #HeartAwarenessMonth #AngioDynamics
0
1
1
0
71
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Feb 4, 2023

Does this make you nervous? $ANGO entered Uptrend as Momentum indicator ascends above 0 level. #AngioDynamics srnk.us/go/4374459

Tickeron's tweet image. Does this make you nervous? $ANGO entered Uptrend as Momentum indicator ascends above 0 level. #AngioDynamics srnk.us/go/4374459
0
0
0
0
31
angiodynamics's profile picture. A leading provider of innovative, minimally invasive medical devices used by healthcare providers for vascular access, peripheral vascular disease, and oncology
AngioDynamics, Inc.
@angiodynamics
Oct 9

We’re proud to announce that the AngioDynamics NanoKnife® System has been named one of @TIME’s Best Inventions of 2025. See the full list ▶️ time.com/collections/be… #AngioDynamics #NanoKnife #TIMEBestInventions #TIME #BestInventions2025 Risk information: bit.ly/3UFe4Rf

angiodynamics's tweet image. We’re proud to announce that the AngioDynamics NanoKnife® System has been named one of @TIME’s Best Inventions of 2025. See the full list ▶️ time.com/collections/be… #AngioDynamics #NanoKnife #TIMEBestInventions #TIME #BestInventions2025 Risk information: bit.ly/3UFe4Rf
0
0
0
0
528
0mr_0ztrk's profile picture. Engineer of Geomatic&Survey. Father. Financial Strategist.
Ömer Öztürk
 @0mr_0ztrk
Jun 17, 2023

#ango #NASDAQ #AngioDynamics 25-30 yıllık grafikte diplerde

0mr_0ztrk's tweet image. #ango #NASDAQ #AngioDynamics 25-30 yıllık grafikte diplerde
0
0
1
0
96

Something went wrong.


Something went wrong.


United States Trends